Loss of p16 INK4A expression is associated with allelic imbalance/loss of heterozygosity of chromosome 9p21 in microdissected synovial sarcomas

Virchows Archiv

Volumn 447, Issue 5, 2005, Pages 842-848

  Sabah, Muna ^a   Cummins, Robert ^a   Leader, Mary ^a   Kay, Elaine ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

9p21; AI LOH; p16INK4A (CDK2A); Synovial sarcoma

Indexed keywords

PROTEIN P16; PROTEIN P16INK4A; DNA;

ALLELIC IMBALANCE; AMINO ACID SEQUENCE; ARTICLE; CHROMOSOME 9P; CONTROLLED STUDY; DNA ISOLATION; GENE AMPLIFICATION; GENE DELETION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICRODISSECTION; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIAL SARCOMA; TUMOR CELL; CHROMOSOME 9; CONNECTIVE TISSUE TUMOR; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; PATHOLOGY; SOFT TISSUE TUMOR;

CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, NEOPLASM; HUMANS; IMMUNOENZYME TECHNIQUES; LOSS OF HETEROZYGOSITY; MICRODISSECTION; POLYMERASE CHAIN REACTION; SARCOMA, SYNOVIAL; SOFT TISSUE NEOPLASMS;

EID: 28444470509     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0024-1     Document Type: Article

References (30)

1. Antonescu CR, Leung DH, Dudas M, Ladanyi M, Brennan M, Woodruff JM, Cordon-Cardo C (2000) Alterations of cell cycle regulators in localized synovial sarcoma: a multifactorial study with prognostic implications. Am J Pathol 156:977-983
2. Butler D, Collins C, Mabruk M, Barry Walsh C, Leader MB, Kay EW (2000) Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features. J Pathol 192:502-510
3. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D (1994) Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415-417
4. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W (1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 11:210-212
5. Cohen JA, Geradts J (1997) Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas. Human Pathol 28:893-898
6. Cordon-Cardo C (1995) Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 147:545-560
7. Cordon-Cardo C (1997) Molecular biology of sarcomas. In: De Vita VT, Hellman S, Rosenberg SA (eds) Principles and practice of oncology. Lippincott, Philadelphia, pp 1731-1738
8. dos Santos NR, de Bruijn DR, van Kessel AG (2001) Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer 30:1-14
9. Golouh R, Stanta G, Bracko M, Bonin S (2001) Correlation of MTS1/p16 and nm23 mRNA expression with survival in patients with peripheral synovial sarcoma. J Surg Oncol 76:83-88
10. Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, Vilain MO, Mandard AM, Le Doussal V, Leroux A, Jacquemier J, Duplay H, Sastre-Garau X, Costa J (1997) Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 15:350-362
11. Hannon GJ, Beach D (1994) p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257-261
12. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440
13. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1:686-692
14. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756
15. Nobori T, Takabayashi K, Tran P, Orvis L, Batova A, Yu AL, Carson DA (1996) Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers. Proc Natl Acad Sci U S A 93:6203-6208
16. Orlow I, Drobnjak M, Zhang ZF, Lewis J, Woodruff JM, Brennan MF, Cordon-Cardo C (1999) Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival. J Natl Cancer Inst 91:73-79
17. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA (1998) The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92:713-723
18. Sabah M, Cummins R, Leader M, Kay E (2004) Loss of heterozygosity of chromosome 9p and loss of p16(INK4A) expression are associated with malignant gastrointestinal stromal tumors. Mod Path 17:1364-1371
19. Sabah M, Cummins R, Leader M, Kay E (2005) Leiomyosarcoma and malignant fibrous histiocytoma share similar allelic imbalance pattern at 9p. Virchows Arch 446:251-258
20. Sabah M, Cummins R, Leader M, Kay E (2005) Loss of p16INK4A expression is associated with allelic imbalance/loss of heterozygosity in microdissected malignant peripheral nerve sheath tumors. Appl Immunohistochem Mol Morphol (in press)
21. Schneider-Stock R, Radig K, Roessner A (1997) Loss of heterozygosity on chromosome 9q21 (p16 gene) uncommon in soft-tissue sarcomas. Mol Carcinog 18:63-65
22. Schneider-Stock R, Walter H, Haeckel C, Radig K, Rys J, Roessner A (1998) Gene alterations at the CDKN2A (p16/MTS1) locus in soft tissue tumors. Int J Oncol 13:325-329
23. Schraml P, Muller D, Bednar R, Gasser T, Sauter G, Mihatsch MJ, Moch H (2000) Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma. J Pathol 190:457-461
24. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707
25. Sherr CJ (1996) Cancer cell cycles. Science 274:1672-1677
26. Skotheim RI, Diep CB, Kraggerud SM, Jakobsen KS, Lothe RA (2001) Evaluation of loss of heterozygosity/allelic imbalance scoring in tumor DNA. Cancer Genet Cytogenet 127:64-70
27. Sotillo R, Dubus P, Martin J, de la Cueva E, Ortega S, Malumbres M, Barbacid M (2001) Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J 20:6637-6647
28. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, De Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C (1984) Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 33:37-42
29. Yao J, Pollock RE, Lang A, Tan M, Pisters PW, Goodrich D, El Naggar A, Yu D (1998) Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma. Clin Cancer Res 4:1065-1070
30. Yoo J, Park SY, Kang SJ, Shim SI, Kim BK (2002) Altered expression of G1 regulatory proteins in human soft tissue sarcomas. Arch Pathol Lab Med 126:567-573